150 related articles for article (PubMed ID: 22749392)
41. Synthesis and cytotoxic activities of E-resveratrol derivatives.
Hong T; Jiang W; Dong HM; Qiu SX; Lu Y
Chin J Nat Med; 2015 May; 13(5):375-82. PubMed ID: 25986287
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and antiproliferative evaluation of 2-hydroxylated (E)-stilbenes.
Zhang Y; Shen M; Cui S; Hou T
Bioorg Med Chem Lett; 2014 Dec; 24(23):5470-2. PubMed ID: 25455486
[TBL] [Abstract][Full Text] [Related]
43. Stilbene-based anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism.
Simoni D; Roberti M; Invidiata FP; Aiello E; Aiello S; Marchetti P; Baruchello R; Eleopra M; Di Cristina A; Grimaudo S; Gebbia N; Crosta L; Dieli F; Tolomeo M
Bioorg Med Chem Lett; 2006 Jun; 16(12):3245-8. PubMed ID: 16580204
[TBL] [Abstract][Full Text] [Related]
44. Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues.
Theeramunkong S; Caldarelli A; Massarotti A; Aprile S; Caprioglio D; Zaninetti R; Teruggi A; Pirali T; Grosa G; Tron GC; Genazzani AA
J Med Chem; 2011 Jul; 54(14):4977-86. PubMed ID: 21696175
[TBL] [Abstract][Full Text] [Related]
45. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
[TBL] [Abstract][Full Text] [Related]
46. Does one keto group matter? Structure-activity relationships of glycyrrhetinic acid derivatives modified at position C-11.
Csuk R; Schwarz S; Kluge R; Ströhl D
Arch Pharm (Weinheim); 2012 Jan; 345(1):28-32. PubMed ID: 22076975
[TBL] [Abstract][Full Text] [Related]
47. Tormentic acid derivatives: synthesis and apoptotic activity.
Csuk R; Siewert B; Dressel C; Schäfer R
Eur J Med Chem; 2012 Oct; 56():237-45. PubMed ID: 22995818
[TBL] [Abstract][Full Text] [Related]
48. Challenges associated with the synthesis of unusual o-carboxamido stilbenes by the Heck protocol: Intriguing substituent effects, their toxicological and chemopreventive implications.
Kee CH; Ariffin A; Awang K; Takeya K; Morita H; Hussain SI; Chan KM; Wood PJ; Threadgill MD; Lim CG; Ng S; Weber JF; Thomas NF
Org Biomol Chem; 2010 Dec; 8(24):5646-60. PubMed ID: 20941451
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents.
Drozdowska D; Rusak M; Miltyk W; Midura-Nowaczek K
Arch Pharm (Weinheim); 2009 Feb; 342(2):87-93. PubMed ID: 19173336
[TBL] [Abstract][Full Text] [Related]
50. Antitumor activity of 3,5,4'-trimethoxystilbene in COLO 205 cells and xenografts in SCID mice.
Pan MH; Gao JH; Lai CS; Wang YJ; Chen WM; Lo CY; Wang M; Dushenkov S; Ho CT
Mol Carcinog; 2008 Mar; 47(3):184-96. PubMed ID: 18085528
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, structural characterisation and biological evaluation of fluorinated analogues of resveratrol.
Moran BW; Anderson FP; Devery A; Cloonan S; Butler WE; Varughese S; Draper SM; Kenny PT
Bioorg Med Chem; 2009 Jul; 17(13):4510-22. PubMed ID: 19481462
[TBL] [Abstract][Full Text] [Related]
52. Synthesis of Novel Imine Stilbene Analogs Exhibiting Potent Anticancer Activity.
Naini R; Ravikumar E; Singh SS; Kancha RK; Rao KV; Reddy VD
Anticancer Agents Med Chem; 2017 Nov; 17(11):1537-1544. PubMed ID: 28356012
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
Csuk R; Schwarz S; Kluge R; Ströhl D
Eur J Med Chem; 2010 Dec; 45(12):5718-23. PubMed ID: 20884085
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and biological evaluation of 1-benzylidene-3,4-dihydronaphthalen-2-one as a new class of microtubule-targeting agents.
Liu J; Zheng CH; Ren XH; Zhou F; Li W; Zhu J; Lv JG; Zhou YJ
J Med Chem; 2012 Jun; 55(12):5720-33. PubMed ID: 22676247
[TBL] [Abstract][Full Text] [Related]
55. Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28.
Siewert B; Pianowski E; Csuk R
Eur J Med Chem; 2013; 70():259-72. PubMed ID: 24161703
[TBL] [Abstract][Full Text] [Related]
56. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.
Maya AB; Pérez-Melero C; Mateo C; Alonso D; Fernández JL; Gajate C; Mollinedo F; Peláez R; Caballero E; Medarde M
J Med Chem; 2005 Jan; 48(2):556-68. PubMed ID: 15658869
[TBL] [Abstract][Full Text] [Related]
57. Design, synthesis and structure-activity relationships of some novel, highly potent anti-invasive (E)- and (Z)-stilbenes.
Roman BI; De Coen LM; Thérèse F C Mortier S; De Ryck T; Vanhoecke BW; Katritzky AR; Bracke ME; Stevens CV
Bioorg Med Chem; 2013 Sep; 21(17):5054-63. PubMed ID: 23867387
[TBL] [Abstract][Full Text] [Related]
58. Synthesis of 1,1,2-triphenylethylenes and their antiproliferative effect on human cancer cell lines.
Zheng L; Wei Q; Zhou B; Yang L; Liu ZL
Anticancer Drugs; 2007 Oct; 18(9):1039-44. PubMed ID: 17704654
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and anti-breast cancer activity of new indolylquinone derivatives.
Li X; Zheng SL; Li X; Li JL; Qiang O; Liu R; He L
Eur J Med Chem; 2012 Aug; 54():42-8. PubMed ID: 22658083
[TBL] [Abstract][Full Text] [Related]
60. Synthesis, antitumor activity and SAR study of novel [1,2,4]triazino[4,5-a]benzimidazole derivatives.
El-Nassan HB
Eur J Med Chem; 2012 Jul; 53():22-7. PubMed ID: 22542105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
